Navigation Links
Isis Receives $1.25 Million Milestone Payment From iCo for Initiation of Phase 1 Study of iCo-007
Date:10/9/2007

CARLSBAD, Calif., Oct. 9 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced that it has received a $1.25 million milestone payment in the form of equity securities in iCo Therapeutics. The milestone was related to the initiation of Phase 1 clinical trials of iCo-007, a drug licensed to iCo by Isis in 2005 for the treatment of various eye diseases, including diabetic macular edema.

"Because our antisense technology enables us to rapidly discover so many highly selective antisense drugs to diverse and important disease targets, we are not able to invest in the development of every promising drug candidate. By licensing drugs at various points in development, we can continue to expand the scope and value of our external pipeline in therapeutic areas that are outside of our key focus, as evidenced by this latest clinical milestone from iCo," said C. Frank Bennett, Ph.D., Senior Vice President of Research at Isis Pharmaceuticals, Inc. "We are enthusiastic about the potential for iCo-007 as a treatment for diabetic macular edema."

About iCo-007

Designed and discovered by Isis, iCo-007 is a second-generation antisense drug that inhibits the production of c-Raf kinase, an enzyme associated with the formation of new and often abnormal or fragile blood vessels in the eye. Blood vessel breakage and leakage can contribute to vision loss, and iCo-007 is expected to decrease swelling in the retina and related visual impairment by decreasing the signaling of various growth factors such as VEGF that signal through the c-Raf kinase / MAP kinase pathway.

About Isis Pharmaceuticals, Inc.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its prod
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Infant receives first bloodless liver transplant
2. British MPs Say Prostate Cancer Receives Low Priority in the NHS
3. Fifth US Patient Receives Artificial Heart
4. Northfield Labs Receives FDA Comments
5. Abbott Receives CE Mark Certification
6. Zactima Receives Fast Track Designation By The FDA
7. East London Receives World Class New Private Hospital Facility
8. Brinda Karat Receives Legal Notice over Ramdev Issue
9. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
10. Medtronic’s Insulin Pump Receives Regulatory Approva
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... of Medicine researchers have made an important advancement ... potentially deadly tick-transmitted disease, human granulocytic anaplasmosis (HGA). ... seen a steady rise in the incidence of ... making the need for a vaccine critical. Successful ... to prevent disease, and the VCU team has ...
(Date:7/29/2014)... A team of scientists, led by Western ... developed a blood test for Alzheimer’s disease risk that ... Alzheimer’s disease interventions, according to an article published July ... this study represents one of several pieces that have ... of years,” Ethell said. , The study, “Women with ...
(Date:7/29/2014)... Most people want to turn back the clock on aging. ... appearance. There are anti aging microcurrent facials and ... help them to look their absolute best. Supreme Skin ... procedures that are noninvasive and they adding some body treatments ... To accommodate, they are also in the process of ...
(Date:7/29/2014)... to cure most cases of cancer is to surgically ... however, is that the surgeon may fail to extract ... With a new technique, researchers at the University of ... see the entire tumor in the patient, increasing the ... an injectable dye that accumulates in cancerous tissues much ...
(Date:7/29/2014)... The report, “Heat Transfer Fluids Market ... Glycol Fluids, & Others), by Application (Oil & Gas, ... - Trends & Forecasts to 2019” defines and segments ... and forecast of the global consumption in terms of ... 64 figures spread through 199 page sand in-depth TOC ...
Breaking Medicine News(10 mins):Health News:Researchers take steps toward development of a vaccine against tick-transmitted disease 2Health News:Researchers take steps toward development of a vaccine against tick-transmitted disease 3Health News:Professor Develops Blood Test for Alzheimer’s Disease Risk 2Health News:Supreme Skin Announces Plans for a Grand Re-opening for Their Noninvasive Anti Aging Microcurrent Face and Body Treatments In Asheville, NC 2Health News:Penn team makes cancer glow to improve surgical outcomes 2Health News:Penn team makes cancer glow to improve surgical outcomes 3Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 2Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 3Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 4
... LENA(TM) Developmental Snapshot is back by popular ... quick and easy way to find out ... ).(Logo: http://www.newscom.com/cgi-bin/prnh/20090210/LA69114 )In the summer ... offered the assessment, more than 13,000 people ...
... Uninsured, including those who are recently unemployed, can attend ... expertPITTSBURGH, March 16 As the nation marks National ... Highmark is offering resources to help Pennsylvanians without health ... the Pennsylvania Insurance Department found that the uninsured ranks ...
... A new study published in Epilepsia ... as high in people with epilepsy compared to the ... seven times the odds of depression in comparison to ... 40 percent of depressed respondents with epilepsy were not ...
... be putting themselves at greater risk of breast cancer ... by Dr. Nisa Maruthur and her team from The ... seriously obese women are significantly less likely to say ... women, especially if they are white. Maruthur,s findings are ...
... The following is being released by the National ... "Waste Not, Want Not: The Right Care for Every ... care that not only costs less but is higher ... advocates and other stakeholders to discuss ways to eliminate ...
... Time for Spring Break and Summer MonthsCOLD SPRING HARBOR, N.Y., ... ear health and creator of EarPlanes(R) and ... ClearEars are revolutionary earplugs containing an FDA approved ... the ears after swimming, or even bathing, can lead to ...
Cached Medicine News:Health News:LENA Foundation Revives Popular Online Child Language Assessment Tool 2Health News:LENA Foundation Revives Popular Online Child Language Assessment Tool 3Health News:Highmark Offers Resources to Help Pennsylvanians Without Health Insurance During Cover the Uninsured Week 2Health News:Highmark Offers Resources to Help Pennsylvanians Without Health Insurance During Cover the Uninsured Week 3Health News:Depression twice as likely in seizure sufferers 2Health News:Obese women play cancer roulette 2Health News:Cleveland Conference: Quality Healthcare Can and Should Cost Less 2Health News:Cleveland Conference: Quality Healthcare Can and Should Cost Less 3Health News:Cleveland Conference: Quality Healthcare Can and Should Cost Less 4Health News:Cleveland Conference: Quality Healthcare Can and Should Cost Less 5Health News:Leader in Ear Care Health Category Expands Product Line 2
(Date:7/29/2014)... LAKE CITY , July 29, 2014  The ... The Grand American Hotel in Salt Lake ... speakers representing some of most respected healthcare organizations in ... Health Catalyst , is an industry conference devoted to ... healthcare analytics,  an essential element of both accountable care ...
(Date:7/29/2014)... , July 29, 2014  Novation, a ... web-based applications with breakthrough interactive features that automate ... for members of Children,s Hospital Association.  ... Novation Optimize Solutions umbrella – Value Analysis, Item ... Novation helps organizations address the most critical challenges ...
(Date:7/29/2014)... , July 29, 2014   Abide Therapeutics ... Thornberry to its board of directors. Thornberry ... Diabetes and Endocrinology for Merck & Co. Inc., ... overall pipeline management in diabetes, osteoporosis, fertility and ... co-led the program that resulted in the discovery ...
Breaking Medicine Technology:Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 2Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 3Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 4Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 5Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 2Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 3Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 4Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 5Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 3
... Wound Care Innovations, LLC,a subsidiary of Wound ... an evidence based study with a NE podiatric ... care collagen,product, CellerateRx(R), on diabetic venous ulcers. "According ... and Prevention, diabetes now,affects nearly 24 million people ...
... Clinical Program Leverages Quark,s RNAi Technology, FREMONT, ... pharmaceutical company discovering and developing novel,RNA interference (RNAi)-based ... patient dosing in a Phase II trial,evaluating, ... (DME)., PF-4523655 is a novel siRNA drug ...
Cached Medicine Technology:Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers 2Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema 2Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema 3Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema 4
... are available in two tip ... tip with staggered eyes, and ... types of catheter valve options, ... fingertip control with virtually no ...
... are available in two tip ... tip with staggered eyes, and ... types of catheter valve options, ... fingertip control with virtually no ...
Sterile Single Loop Pediatric Suction Catheters with TOUCH-TROL Valve...
Catheter Suction 14FR Sterile W/Control Valve...
Medicine Products: